Evidence map›Paper›PMID 32303716›Full record

ArticleBritish journal of cancer2020

Correction: miR-27a is a master regulator of metabolic reprogramming and chemoresistance in colorectal cancer.

Giovannina Barisciano, Tommaso Colangelo, Valeria Rosato, Livio Muccillo, Maria Letizia Taddei, Luigi Ippolito, Paola Chiarugi, Mario Galgani, Sara Bruzzaniti, Giuseppe Matarese and 9 more

Open access · hybridAbstract readPublished Erratum
PubMed Full text at PMC Publisher
In one paragraph

Article in British journal of cancer, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
0.1field-weighted citation impact, top 63% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 1 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

19 authors at 6 institutions in 1 country.

Giovannina Barisciano *Department of Sciences and Technologies, University of Sannio, Via Francesco de Sanctis, 82100, Benevento, Italy.
Tommaso Colangelo *Fondazione IRCCS Casa Sollievo della Sofferenza, Cancer Biomarkers Unit, Viale Padre Pio, 7, 71013, San Giovanni Rotondo, FG, Italy.
Valeria Rosato *Department of Sciences and Technologies, University of Sannio, Via Francesco de Sanctis, 82100, Benevento, Italy.
Livio MuccilloDepartment of Sciences and Technologies, University of Sannio, Via Francesco de Sanctis, 82100, Benevento, Italy.
Maria Letizia TaddeiDepartment of Experimental Biomedical and Clinical Medicine, University of Florence, Viale Morgagni 50, 50134, Florence, Italy.
Luigi IppolitoDepartment of Experimental Biomedical and Clinical Medicine, University of Florence, Viale Morgagni 50, 50134, Florence, Italy.
Paola ChiarugiDepartment of Experimental Biomedical and Clinical Medicine, University of Florence, Viale Morgagni 50, 50134, Florence, Italy.
Mario GalganiDepartment of Molecular Medicine and Medical Biotechnologies "Federico II", University, Naples Via S. Pansini, 5, 80131, Naples, Italy.
Sara BruzzanitiDepartment of Biology, "Federico II" University, 80126, Naples, Italy.
Giuseppe MatareseDepartment of Molecular Medicine and Medical Biotechnologies "Federico II", University, Naples Via S. Pansini, 5, 80131, Naples, Italy.
Matteo FassanDepartment of Medicine (DIMED), Surgical Pathology Unit, University of Padua, Via Giustiniani, 2, 35128, Padua, Italy.
Marco AgostiniDepartment of Surgery, Oncology and Gastroenterology, First Surgical Clinic Section, University of Padua, Via Giustiniani, 2, 35128, Padua, Italy.
Francesca BergamoDepartment of Clinical and Experimental Oncology, Unit of Medical Oncology 1, Veneto Institute of Oncology IOV, IRCCS, Via Gattamelata, 64, 35128, Padua, Italy.
Salvatore PucciarelliDepartment of Surgery, Oncology and Gastroenterology, First Surgical Clinic Section, University of Padua, Via Giustiniani, 2, 35128, Padua, Italy.
Annalucia CarboneFondazione IRCCS Casa Sollievo della Sofferenza, Division of Internal Medicine and Chronobiology Unit, Viale Padre Pio, 7, 71013, San Giovanni Rotondo, FG, Italy.
Gianluigi MazzoccoliFondazione IRCCS Casa Sollievo della Sofferenza, Division of Internal Medicine and Chronobiology Unit, Viale Padre Pio, 7, 71013, San Giovanni Rotondo, FG, Italy.
Vittorio ColantuoniDepartment of Sciences and Technologies, University of Sannio, Via Francesco de Sanctis, 82100, Benevento, Italy.
Fabrizio BianchiFondazione IRCCS Casa Sollievo della Sofferenza, Cancer Biomarkers Unit, Viale Padre Pio, 7, 71013, San Giovanni Rotondo, FG, Italy. f.bianchi@operapadrepio.it.
Lina SabatinoDepartment of Sciences and Technologies, University of Sannio, Via Francesco de Sanctis, 82100, Benevento, Italy. sabat@unisannio.it.
University of Sannio · ITCasa Sollievo della Sofferenza · ITFederico II University Hospital · ITUniversity of Florence · ITUniversity of Padua · ITIstituto Oncologico Veneto · IT

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID32303716
PMCPMC7217760
OpenAlexW3017285616

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.